Search
for
Sort by
Research 121–150 of 821
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Anabolic–Androgenic Steroids and Brain Damage: A Review of Evidence and Medico-Legal Implications
- Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents
- Monocyclic Aromatic Compounds
- Androgenic disorders
- Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens
- Diffuse hair loss associated with hyperprolactinaemia: report of three cases
- Caffeine’s Mechanisms of Action and Its Cosmetic Use
- Effect of ethanol Adiantum capillus-veneris extract in experimental models of anxiety and depression
- Poster Abstracts
- Adverse effects of common medications on male fertility
- Isoallopregnanolone reduces tic‐like behaviours in the D1 CT ‐7 mouse model of Tourette syndrome
- Adrenal causes of endocrine hypertension in childhood or adolescence
- Innervated Biomaterials for Improved Cutaneous Wound Healing: A Review of Recent Advancements and Future Prospects
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Neural Mechanisms of Hair Growth Control
- Dermatologic manifestations of endocrine disorders
- The control of hair growth: An overview
- Parkinson's disease and skin
- Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Skin diseases in consequence of endocrine alterations
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Hyperadrenocorticism in Ferrets
- Hormones
- Treatment of female sexual dysfunction in postmenopausal women—What is the evidence?
- Endocrine Regulation of Hair Growth and Loss: Current Evidence and Clinical Implications
- Menopause - Andropause - Anti-Aging 2008, 11.-13. Dezember 2008, Wien - Abstracts
- Alterations in androgen conjugate levels in women and men with alopecia